CD8A and neoplasm: Indicators of the immunotherapeutic effect included TEM and TCM activation in the spleen, tumor infiltration of CD8 + cytotoxic T lymphocytes (CTLs), Th2 cells, and increased secretion of IL-6, IFN-γ, and TNF-α (Figure 11) (Xia et al. 2021).